NSE filing, NSE: MBAPL. Summary written from the filing by ALFA Finder's alert engine.
Madhya Bharat Agro Products Ltd: key numbers
- Share price
- ₹174.00
- Market cap
- ₹7,984 Cr
- Revenue (annual)
- ₹1,867 Cr
- Net profit (annual)
- ₹150.2 Cr
- P/E (TTM)
- 51.5×Sector 9.7×
- Promoter holding
- 71.38%-3.38% QoQ
- FII holding
- 0.88%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Madhya Bharat Agro Products Ltd
All →Madhya Bharat Agro Products Production Started
Madhya Bharat Agro Products Limited has successfully commenced commercial production at its phosphoric acid plant in Dhule, Maharashtra. The facility has a capacity of 300 TPD.
- phosphoric acid production
- 300.0 TPD
Madhya Bharat Agro Products Capital Structure Change
MBAPL completed a preferential allotment of 20.72 lakh equity shares at ₹145 to 14 investors. The issuance raises ₹30.05 Crore, expanding paid-up capital to ₹91.77 Crore.
- Value
- ₹30.05 Cr
Madhya Bharat Agro Products Capital Structure Change
Madhya Bharat Agro Products allotted 2.07 crore shares at ₹145 in a preferential issue, raising ₹300.48 Crore. Post-allotment paid-up capital stands at 4.59 crore equity shares.
- Value
- ₹300.5 Cr
Madhya Bharat Agro Products Annual General Meeting
Madhya Bharat Agro Products Limited conducted an EGM on August 28, 2026. Shareholders approved a preferential equity issue to non-promoters and an amendment to the Company's Memorandum of Association.
Madhya Bharat Agro Products Annual General Meeting
Madhya Bharat Agro issued a corrigendum to its August 28, 2026 EGM notice, modifying the list of allottees for its proposed Rs 317.48 Crore preferential issue.
- Value
- ₹317.5 Cr
Madhya Bharat Agro Products Annual General Meeting
Madhya Bharat Agro Products Limited issued an EGM notice for August 28, 2026, seeking approval for a preferential issue aggregating ₹317.48 Crore.
- Value
- ₹317.5 Cr
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.